サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/02/25 | 1,702 | 1,757 | 1,702 | 1,744 | +50 | +3% | 208,200 |
2021/02/24 | 1,736 | 1,757 | 1,686 | 1,694 | -57 | -3.3% | 277,300 |
2021/02/22 | 1,718 | 1,767 | 1,718 | 1,751 | +41 | +2.4% | 234,900 |
2021/02/19 | 1,782 | 1,793 | 1,682 | 1,710 | -90 | -5% | 383,600 |
2021/02/18 | 1,781 | 1,819 | 1,768 | 1,800 | +22 | +1.2% | 363,300 |
2021/02/17 | 1,704 | 1,784 | 1,700 | 1,778 | +70 | +4.1% | 391,500 |
2021/02/16 | 1,727 | 1,746 | 1,703 | 1,708 | -19 | -1.1% | 184,500 |
2021/02/15 | 1,750 | 1,752 | 1,711 | 1,727 | -26 | -1.5% | 207,300 |
2021/02/12 | 1,730 | 1,757 | 1,708 | 1,753 | +21 | +1.2% | 199,400 |
2021/02/10 | 1,660 | 1,733 | 1,657 | 1,732 | +61 | +3.7% | 228,500 |
2021/02/09 | 1,717 | 1,718 | 1,667 | 1,671 | -49 | -2.8% | 323,000 |
2021/02/08 | 1,741 | 1,774 | 1,717 | 1,720 | -29 | -1.7% | 250,800 |
2021/02/05 | 1,731 | 1,768 | 1,723 | 1,749 | +24 | +1.4% | 259,200 |
2021/02/04 | 1,728 | 1,737 | 1,702 | 1,725 | -13 | -0.7% | 201,900 |
2021/02/03 | 1,750 | 1,808 | 1,715 | 1,738 | -28 | -1.6% | 415,100 |
2021/02/02 | 1,694 | 1,776 | 1,691 | 1,766 | +65 | +3.8% | 516,800 |
2021/02/01 | 1,605 | 1,713 | 1,590 | 1,701 | +64 | +3.9% | 333,800 |
2021/01/29 | 1,690 | 1,730 | 1,625 | 1,637 | -55 | -3.3% | 445,000 |
2021/01/28 | 1,675 | 1,716 | 1,673 | 1,692 | -39 | -2.3% | 295,100 |
2021/01/27 | 1,690 | 1,733 | 1,690 | 1,731 | +51 | +3% | 227,400 |
2021/01/26 | 1,736 | 1,745 | 1,672 | 1,680 | -65 | -3.7% | 276,400 |
2021/01/25 | 1,747 | 1,756 | 1,717 | 1,745 | +5 | +0.3% | 256,200 |
2021/01/22 | 1,702 | 1,746 | 1,690 | 1,740 | +20 | +1.2% | 272,200 |
2021/01/21 | 1,708 | 1,729 | 1,685 | 1,720 | +29 | +1.7% | 311,600 |
2021/01/20 | 1,700 | 1,710 | 1,650 | 1,691 | -5 | -0.3% | 285,400 |
2021/01/19 | 1,650 | 1,711 | 1,634 | 1,696 | +43 | +2.6% | 448,200 |
2021/01/18 | 1,609 | 1,678 | 1,609 | 1,653 | +56 | +3.5% | 519,400 |
2021/01/15 | 1,591 | 1,613 | 1,583 | 1,597 | +13 | +0.8% | 225,000 |
2021/01/14 | 1,580 | 1,620 | 1,571 | 1,584 | -11 | -0.7% | 333,000 |
2021/01/13 | 1,631 | 1,650 | 1,588 | 1,595 | -57 | -3.5% | 431,000 |
2021/01/12 | 1,585 | 1,664 | 1,585 | 1,652 | +95 | +6.1% | 728,800 |
2021/01/08 | 1,570 | 1,600 | 1,537 | 1,557 | -12 | -0.8% | 573,500 |
2021/01/07 | 1,634 | 1,674 | 1,554 | 1,569 | -58 | -3.6% | 1,289,700 |
2021/01/06 | 1,477 | 1,671 | 1,460 | 1,627 | +166 | +11.4% | 1,699,000 |
2021/01/05 | 1,445 | 1,516 | 1,423 | 1,461 | +71 | +5.1% | 1,454,900 |
2021/01/04 | 1,338 | 1,396 | 1,318 | 1,390 | +53 | +4% | 560,000 |
2020/12/30 | 1,346 | 1,346 | 1,314 | 1,337 | -18 | -1.3% | 425,600 |
2020/12/29 | 1,319 | 1,372 | 1,313 | 1,355 | +36 | +2.7% | 396,000 |
2020/12/28 | 1,313 | 1,323 | 1,285 | 1,319 | -4 | -0.3% | 540,100 |
2020/12/25 | 1,326 | 1,352 | 1,318 | 1,323 | -8 | -0.6% | 387,300 |
2020/12/24 | 1,326 | 1,344 | 1,311 | 1,331 | -1 | -0.1% | 453,300 |
2020/12/23 | 1,330 | 1,342 | 1,308 | 1,332 | -4 | -0.3% | 496,100 |
2020/12/22 | 1,363 | 1,384 | 1,335 | 1,336 | -5 | -0.4% | 571,400 |
2020/12/21 | 1,410 | 1,413 | 1,333 | 1,341 | -64 | -4.6% | 910,600 |
2020/12/18 | 1,420 | 1,433 | 1,395 | 1,405 | -19 | -1.3% | 835,800 |
2020/12/17 | 1,525 | 1,588 | 1,395 | 1,424 | +36 | +2.6% | 3,277,300 |
2020/12/16 | 1,388 | 1,388 | 1,388 | 1,388 | -400 | -22.4% | 168,000 |
2020/12/15 | 1,809 | 1,814 | 1,777 | 1,788 | -39 | -2.1% | 406,100 |
2020/12/14 | 1,804 | 1,847 | 1,790 | 1,827 | -53 | -2.8% | 429,000 |
2020/12/11 | 1,890 | 1,909 | 1,863 | 1,880 | +28 | +1.5% | 383,100 |
1101~
1150
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム